newsfilter
← Latest News
GlobeNewswire·

BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today's Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expeditiously

  • BIO-key International, Inc. (NASDAQ: BKYI) stock trading was suspended by Nasdaq effective May 12, 2026, due to non-compliance with listing standards.
  • The suspension occurred because the company failed to maintain a closing bid price above $1 for the required ten consecutive trading days by the May 4, 2026 deadline.
  • BIO-key also remains in violation of Nasdaq rules for not yet filing its Annual Report on Form 10-K for the year ended December 31, 2025.
  • The company has received approval from OTC Markets Group to quote its shares under the same symbol starting May 13, 2026, to provide liquidity during the suspension.
  • BIO-key intends to request a hearing before a Nasdaq Hearings Panel to demonstrate compliance & seek resumption of trading, though no guarantee of success exists.
  • The company implemented a 1-for-10 reverse split effective April 30, 2026, to restore the share price above $1, but the timing prevented meeting the 10-day compliance window before the May 4 deadline.
  • Nasdaq updated its rules in early 2026 to require 10 calendar days of advance notice for reverse splits & to mandate immediate suspension for bid price non-compliance after 360 days.
  • CEO Michael DePasquale stated the business is in a strong position with a growing recurring revenue base & a streamlined cost structure.
  • BIO-key projects 2026 first-half revenues to rise 50% to $5M, achieve profitability, & maintain cash levels consistent with year-end 2025.
  • The company is retaining expert listing consultants to assist in corrective measures aimed at expeditiously resolving the suspension.